Independent Retail Pharmacy Owners and Community Pharmacists Use McKesson's Pharmacy Intervention Program to Balance Business Needs with Patient Care
MCKESSON IDEASHARE — Las Vegas — June 26, 2012 — McKesson, the largest healthcare services company in the country, today showcased its Sponsored Clinical Services Network – the largest active patient support network with significant experience implementing adherence support programs – to hundreds of independent retail pharmacy owners and community pharmacists in attendance at McKesson ideaShare 2012. Community pharmacies who are focused on elevating their role in healthcare delivery, enhancing patient loyalty and outcomes, and seeking new reimbursement streams are adopting sophisticated behavioral adherence programs into their practice.
“McKesson is committed to helping community pharmacists achieve their goals with pharmacy-based adherence programs centered on the patient,” said Brian Tyler, president, U.S. Pharmaceutical. “With McKesson’s partnership with many of the largest pharmaceutical manufacturers in the industry, pharmacies active in the McKesson Sponsored Clinical Services Network have been assuming an even greater role in providing patient care and services, in addition to growing their revenues. In fact, in 2011, pharmacies in our Sponsored Clinical Services Network earned $1 million in service fees for providing patient support services and supported an estimated quarter of a million patients.”
McKesson’s Pharmacy Intervention Program, which expands patient access to one-on-one behavioral coaching from their retail pharmacists, is helping to achieve better patient care, enhance the role of the pharmacists and transition the pharmacy to a service-based business model. McKesson’s Pharmacy Intervention Program found patients who received face-to-face behavioral coaching from their pharmacists showed significant adherence benefits. For example, COPD patients who received coaching showed an average of 1.6 incremental fills over 12 months and patients coached in multiple diabetes programs showed an average of 4 incremental refills over 12 months when compared to patients who did not receive behavioral coaching.
The results indicate that the Pharmacy Intervention Program’s pharmacist training, coaching session design and ongoing resources are driving patient compliance to their medication regimens, which in turn drive increased visits and revenues to the pharmacy. In addition to reimbursement fees from sponsors associated with coaching sessions, pharmacies can benefit from increased prescription volumes, incremental front-end purchases and further enhance customer loyalty.
"Fostering patient loyalty and healthier outcomes is not only key to growing my business, but part of my role as a trusted healthcare provider in my community," said Christine Jacobson, owner , Wasatch Pharmacy Care (Ogden, UT). "By participating in McKesson's Pharmacy Intervention Program, I benefit from being part of the largest active patient support pharmacy network. This program is one example of how my wholesaler is helping me to increase prescription volumes and customer loyalty - ultimately driving better outcomes for my patients and my business."
For more information on all of McKesson's announcements from McKesson ideaShare 2012, please visit McKesson's online newsroom at www.mckesson.com/newsroom.
McKesson Corporation, currently ranked 14th on the FORTUNE 500, is a healthcare services and information technology company dedicated to making the business of healthcare run better. We partner with payers, hospitals, physician offices, pharmacies, pharmaceutical companies and others across the spectrum of care to build healthier organizations that deliver better care to patients in every setting. McKesson helps its customers improve their financial, operational, and clinical performance with solutions that include pharmaceutical and medical-surgical supply management, healthcare information technology, and business and clinical services. For more information, visit http://www.mckesson.com.
McKesson U.S. Pharmaceutical